Patents by Inventor Cyril Desevaux

Cyril Desevaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES
    Publication number: 20140343085
    Abstract: The present invention relates to the use of compounds of formula (I), wherein the variables are as defined in the description, in the free form or in salt form, for the manufacture of a medicament for controlling ectoparasites on a warm-blooded animal, wherein said medicament is administered orally to the animal at a dose of from 0.1 to 100 mg/kg from 30 minutes before to 3 hours after feeding the animal with an animal food.
    Type: Application
    Filed: November 23, 2012
    Publication date: November 20, 2014
    Applicant: Novartis AG
    Inventors: Cyril Desevaux, Martin Jung, Caroline Kablitz, Steve Nanchen
  • Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
    Publication number: 20040013726
    Abstract: The present invention relates to a novel form of cross-linked high amylose starch and processes for its manufacture. Such cross-linked high amylose starch is useful as an excipient in a controlled-release pharmaceutical formulation when compressed with pharmaceutical agent(s) in a tablet. Such cross-linked high amylose starch is prepared by (a) cross-linking and chemical modification of high amylose starch, (b) gelatinization, and (c) drying to obtain a powder of said controlled release excipient. In a preferred embodiment, such cross-linked high amylose starch is prepared in the following steps: (1) granular cross-linking and additional chemical modification (e.g., hydroxypropylation) of high-amylose starch; (2) thermal gelatinization of the starch from step (1); and (3) drying the starch from step (2) to yield a powder capable of being used as a controlled release excipient.
    Type: Application
    Filed: July 14, 2003
    Publication date: January 22, 2004
    Inventors: Vincent Lenaerts, Roland Herwig Friedrich Beck, Elsie Van Bogaert, Francois Chouinard, Reiner Hopcke, Cyril Desevaux
  • Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
    Patent number: 6607748
    Abstract: The present invention relates to a novel form of cross-linked high amylose starch and processes for its manufacture. Such cross-linked high amylose starch is useful as an excipient in a controlled-release pharmaceutical formulation when compressed with pharmaceutical agent(s) in a tablet. Such cross-linked high amylose starch is prepared by (a) cross-linking and chemical modification of high amylose starch, (b) gelatinization, and (c) drying to obtain a powder of said controlled release excipient. In a preferred embodiment, such cross-linked high amylose starch is prepared in the following steps: (1) granular cross-linking and additional chemical modification (e.g., hydroxypropylation) of high-amylose starch; (2) thermal gelatinization of the starch from step (1); and (3) drying the starch from step (2) to yield a powder capable of being used as a controlled release excipient.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: August 19, 2003
    Inventors: Vincent Lenaerts, Roland Herwig Friedrich Beck, Elsie Van Bogaert, Francois Chouinard, Reiner Höpcke, Cyril Désévaux